AFT Forsyth & Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$299K	Buy	3,447 +7	+0.2%	+$613	0.14%	104
2025 Q4	$292K	Buy	3,440 +15	+0.4%	+$1.2K	0.13%	105
2025 Q3	$249K	Sell	3,425 -15	-0.4%	-$1.03K	0.12%	105
2025 Q2	$225K	Buy	3,440 +10	+0.3%	+$651	0.12%	106
2025 Q1	$242K	Buy	3,430 +9	+0.3%	+$625	0.13%	117
2024 Q4	$225K	Sell	3,421 -103	-3%	-$7.09K	0.11%	119
2024 Q3	$249K	Buy	3,524 +12	+0.3%	+$836	0.12%	118
2024 Q2	$233K	Buy	3,512 +10	+0.3%	+$655	0.11%	129
2024 Q1	$238K	Buy	3,502 +7	+0.2%	+$463	0.14%	126
2023 Q4	$216K	Sell	3,495 -480	-12%	-$28.2K	0.14%	127
2023 Q3	$234K	Hold	3,975	–	–	0.17%	112
2023 Q2	$237K	Buy	3,975 +9	+0.2%	+$535	0.17%	119
2023 Q1	$232K	Sell	3,966 -42	-1%	-$2.53K	0.18%	123
2022 Q4	$249K	Sell	4,008 -24	-0.6%	-$1.44K	0.21%	118
2022 Q3	$228K	Hold	4,032	–	–	0.2%	120
2022 Q2	$258K	Buy	4,032 +9	+0.2%	+$571	0.21%	118
2022 Q1	$261K	Buy	4,023 +9	+0.2%	+$571	0.17%	128
2021 Q4	$267K	Buy	4,014 +45	+1%	+$2.85K	0.14%	134
2021 Q3	$242K	Hold	3,969	–	–	0.13%	139
2021 Q2	$246K	Buy	3,969 +318	+9%	+$19.3K	0.13%	141
2021 Q1	$216K	Hold	3,651	–	–	0.13%	145
2020 Q4	$218K	Buy	+3,651	New	+$208K	0.14%	138
2020 Q1	–	Sell	-4,074	Closed	-$217K	–	135
2019 Q4	$217K	Buy	+4,074	New	+$201K	0.17%	132
2019 Q3	–	Sell	-4,314	Closed	-$217K	–	140
2019 Q2	$217K	Sell	4,314 -672	-13%	-$33.2K	0.18%	131
2019 Q1	$256K	Sell	4,986 -270	-5%	-$13.4K	0.22%	120
2018 Q4	$247K	Buy	5,256 +1,470	+39%	+$75.4K	0.25%	119
2018 Q3	$212K	Buy	+3,786	New	+$207K	0.18%	134
2018 Q2	–	Sell	-4,161	Closed	-$205K	–	142
2018 Q1	$205K	Hold	4,161	–	–	0.19%	131
2017 Q4	$214K	Buy	+4,161	New	+$214K	0.21%	124
2013 Q3	$63K	Buy	1,785 +1,185	+198%	+$41.7K	0.08%	157
2013 Q2	$20K	Buy	+600	New	+$19.9K	0.03%	223